Overview

Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis

Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who don´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Fundación Pública Andaluza Progreso y Salud
Treatments:
Hyaluronic Acid
Hylan
Criteria
Inclusion Criteria:

- Patients> 30 years.

- Patients who voluntarily express their intention to participate by informed consent.

- Diagnosis of coxarthrosis who have failed conservative treatments for 6 months

- Women of childbearing potential must have a negative pregnancy test during screening
and must agree to use adequate contraception (or two contraceptive methods, of which
one is barrier) while participating in the trial.

Exclusion Criteria:

- Treatment with infiltrations 3 months prior to the study

- Prior treatment with NSAIDs 24h prior to extraction

- Pre-Surgical Treatment of Hip affects

- Diabetics

- Severe liver or kidney disease at the time of extraction

- Thrombocytopenia (<100,000 platelets / ml) at baseline

- Anemia (Hb 9
- Hyaluronic acid Allergy

- History crystal arthropathy, inflammatory arthritis or neuropathic arthropathy.

- Acetabular protrusions

- History of infectious arthritis

- Excessive deformity (acetabular dysplasia, Perthes)